Two developments often get lost in the public’s perception of the abortion wars. One is that the number of abortions in the U.S. has increased dramatically year over year since the U.S. Supreme Court overturned Roe v. Wade in 2022, according to the Society of Family Planning’s latest #WeCount report. By December, 29% of abortions were through telehealth. The second is that, because the mailing of abortion pills has become so widespread in the post-Dobbs era, abortion opponents may simply be unable to stop it.

A rare strain of Ebola that began spreading undetected in eastern Democratic Republic of Congo (DRC) in early April 2026 has now confirmed transmission in Uganda and is potentially on course to reach South Sudan, according to a new modeling study from the World Health Organization (WHO) published in The Lancet Infectious Diseases.

Patients with severe injuries from car crashes are about 70% less likely to be transferred to another hospital in states with no-fault insurance laws than in states with more common at-fault policies, reports a new study led by Northwestern Medicine. The findings suggest that policies such as no-fault laws—which guarantee reimbursement for trauma care—may incentivize hospitals to keep and treat seriously injured patients. The work is published in the journal Injury.

Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, have found a link between a bacterium in the gut microbiome (ecosystem) and lupus that could lead to more effective treatment of the disease, described in a study published in Nature Communications.

A research team led by Prof. Liu Qingsong at the Institute of Health and Medical Technology, the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has discovered a new drug candidate that may help overcome chemotherapy resistance in small cell lung cancer (SCLC). The study, published in Signal Transduction and Targeted Therapy, introduces a compound called IHMT-15137, which works by blocking a key signaling pathway linked to drug resistance.